Libtayo plus chemotherapy is potentially more cost-effective than Keytruda plus chemotherapy for advanced NSCLC, offering lower costs and higher QALYs. The study's model, based on clinical trial data, ...

National Anti-Drugs Agency (AADK) director-general Datuk Ruslin Jusoh said 156,316 cases were recorded as of September this year, compared to 169,691 cases for the same period in 2024.

Synthekine Inc., an engineered cytokine therapeutics company, today announced that the company has dosed the first patient in the SYNERGY-101 study. SYNERGY-101 is a global, randomized Phase 2 ...

The therapeutic target against memory impairments in Down syndrome gains strength. The experimental, long-term pharmacological treatment in a mice model for Down syndrome to reduce the activity of ...

The 2nd India-South Africa test match will be televised on the Star Sports Network in India. The 2nd India vs South Africa ...

New research has revealed that a 10% lactate clearance threshold is a stronger predictor of in-hospital mortality for ...

Synthekine has reported positive initial data from a Phase Ia/Ib trial evaluating STK-012 in first-line, programmed ...

The credit rating agency S&P Global Ratings (S&P) upgraded the credit rating of the Central American Bank for Economic Integration (CABEI) from "AA" to "AA+." This result marks the fourth positive ...

A study reveals over 80 pct of Indian patients carry multidrug-resistant organisms, placing India at the centre of a growing ...

Mumbai doctors highlight, ahead of World Diabetes Day 2025 observed on November 14 every year, that more people need to do ...

The ruling Liberal Democratic Party has affirmed plans to begin discussions on Thursday for revising Japan's three key national security-related documents. The decision was made Tuesday at an executiv ...